154 related articles for article (PubMed ID: 8539880)
1. Combined pancreas-kidney transplants using quadruple immunosuppression therapy: a comparison between antilymphoblast and antithymocyte globulins.
Fasola CG; Hricik DE; Schulak JA
Transplant Proc; 1995 Dec; 27(6):3135-6. PubMed ID: 8539880
[No Abstract] [Full Text] [Related]
2. Severe kidney graft rejection in combined kidney and pancreas transplantation.
Hedman L; Frisk B; Brynger H; Frödin L; Tufveson G; Wahlberg J
Transplant Proc; 1987 Oct; 19(5):3911-2. PubMed ID: 3313961
[TBL] [Abstract][Full Text] [Related]
3. Successful pancreas-renal transplantation without anti-T-cell antibody induction.
Shapiro ME; Abrams JM; Brown RS; Steinman TI; Strom TB
Transplant Proc; 1995 Dec; 27(6):3087-8. PubMed ID: 8539857
[No Abstract] [Full Text] [Related]
4. A prospective randomized comparison of antilymphoblast globulin versus antithymocyte globulin for cadaver kidney transplantation.
Toledo-Pereyra LH; Bergren C; Mittal VK; Whitten JI; Baskin S; McNichol L
Transplantation; 1985 Oct; 40(4):448-50. PubMed ID: 3901446
[No Abstract] [Full Text] [Related]
5. Pancreas transplant outcome with or without biological anti-T-cell therapy for induction immunosuppression with use of cyclosporine.
Sutherland DE; Moudry-Munns KC; Gruessner A
Transplant Proc; 1994 Oct; 26(5):2752-5. PubMed ID: 7940866
[No Abstract] [Full Text] [Related]
6. A prospective randomized trial of OKT3 vs ATGAM induction therapy in pancreas transplant recipients.
Stratta RJ; Taylor RJ; Weide LG; Sindhi R; Sudan D; Castaldo P; Cushing KA; Frisbie K; Radio SJ
Transplant Proc; 1996 Apr; 28(2):917-8. PubMed ID: 8623461
[No Abstract] [Full Text] [Related]
7. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
Guttmann RD; Flemming C
Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
[TBL] [Abstract][Full Text] [Related]
8. Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation.
Freise CE; Kang SM; Feng S; Posselt A; Hirose K; Hirose R; Stock P
Transplant Proc; 2004 May; 36(4):1067-8. PubMed ID: 15194370
[TBL] [Abstract][Full Text] [Related]
9. Antilymphocyte induction immunosuppression in the post-Minnesota anti-lymphocyte globulin era: incidence of renal dysfunction and delayed graft function. A single center experience.
Malinow L; Walker J; Klassen D; Oldach D; Schweitzer E; Bartlett ST; Weir MR
Clin Transplant; 1996 Jun; 10(3):237-42. PubMed ID: 8826659
[TBL] [Abstract][Full Text] [Related]
10. Rejection prophylaxis with antilymphocyte globulin for cardiac transplantation in Oriental recipients.
Wei J; Chang CY; Lee FY; Song YB; Jiau SF
Transplant Proc; 1992 Aug; 24(4):1493-7. PubMed ID: 1496632
[No Abstract] [Full Text] [Related]
11. Risk factors of long-term survivals in combined kidney/pancreas transplantation: a multivariate analysis of 259 recipients.
Tso PL; Elkhammas EA; Henry ML; Kim SI; Davies EA; Bumgardner GL; Ferguson RM
Transplant Proc; 1995 Dec; 27(6):3104. PubMed ID: 8539865
[No Abstract] [Full Text] [Related]
12. Tolerance of peripheral veins to antithymocyte globulin after heart transplantation.
Cantarovich M; Latter DA
J Heart Lung Transplant; 1994; 13(4):737. PubMed ID: 7947896
[No Abstract] [Full Text] [Related]
13. Minnesota experience with 81 pancreas transplants since 1978.
Sutherland DE; Chinn PL; Goetz FC; Elick BA; Najarian JS
Transplant Proc; 1984 Jun; 16(3):695-703. PubMed ID: 6375036
[No Abstract] [Full Text] [Related]
14. Survival of tumor allografts in rats treated with antithymocyte serum.
Abandowitz HM; Basrur PK
Z Naturforsch C; 1973; 28(9):631-2. PubMed ID: 4272308
[No Abstract] [Full Text] [Related]
15. Use of antilymphocyte induction therapy in liver transplantation: A European perspective.
Langrehr JM; Neuhaus PJ
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S71-84. PubMed ID: 10431020
[No Abstract] [Full Text] [Related]
16. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
Schulz T; Kapischke M; Busing M
Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
[TBL] [Abstract][Full Text] [Related]
17. Rapid T cell recovery after prophylactic ALG is associated with pancreas allograft rejection.
Munn SR; Perkins JD
Transplant Proc; 1990 Apr; 22(2):619. PubMed ID: 2139264
[No Abstract] [Full Text] [Related]
18. Rabbit antithymocyte globulin as induction immunotherapy for pediatric deceased donor kidney transplantation.
Kamel MH; Mohan P; Little DM; Awan A; Hickey DP
J Urol; 2005 Aug; 174(2):703-7. PubMed ID: 16006954
[TBL] [Abstract][Full Text] [Related]
19. Outcome of cadaveric renal transplantation by induction treatment in the cyclosporine era.
Hariharan S; Alexander JW; Schroeder TJ; First MR
Clin Transplant; 1996 Apr; 10(2):186-90. PubMed ID: 8664516
[TBL] [Abstract][Full Text] [Related]
20. Cadaveric kidney transplantation under prophylactic polyclonal antibody immunosuppression with anti-lymphoblast globulin versus anti-thymocyte globulin.
Indudhara R; Novick AC; Hodge E; Goormastic M; Papajcik D; Mastroianni B; Cook D
Urology; 1996 Jun; 47(6):807-12. PubMed ID: 8677568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
